KAT2A and neoplasm: This action effectively impedes the proliferation of liver cancer cells and disrupts the glycolytic pathway.188 One research indicates that suppressing the expression of succinyltransferases, such as KAT2A, reduces tumor cell proliferation and overall tumor growth.126 This suggests a promising approach for utilizing histone succ in tumor therapies.